Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 2 (2005), Issue 8 (August)

1. Repopulation of cancer cells during therapy: an important cause of treatment failure.
   Nat Rev Cancer, 5(7): 516-25. [Abstract] [Full-text]
2. Calculations of neutron dose equivalent exposures from range-modulated proton therapy beams.
   Phys Med Biol, 50(16): 3859-73. [Abstract] [Full-text]
3. An application of Bayesian statistical methods to adaptive radiotherapy.
   Phys Med Biol, 50(16): 3849-58. [Abstract] [Full-text]
4. A technique for respiratory-gated radiotherapy treatment verification with an EPID in cine mode.
   Phys Med Biol, 50(16): 3669-79. [Abstract] [Full-text]
5. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy.
   Acta Oncol, 44(3): 265-76. [Abstract] [Full-text]
6. Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison.
   Br J Cancer, 93(3): 279-86. [Abstract] [Full-text]
7. Pro-gastrin-releasing peptide as a factor predicting the incidence of brain metastasis in patients with small cell lung carcinoma with limited disease receiving prophylactic cranial irradiation.
   Cancer, 104(4): 811-6. [Abstract] [Full-text]
8. First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma.
   Cancer, 104(4): 763-70. [Abstract] [Full-text]
9. Comparison of end normal inspiration and expiration for gated intensity modulated radiation therapy (IMRT) of lung cancer.
   Radiother Oncol, 75(2): 149-56. [Abstract] [Full-text]
10. Evaluation of the Sinmed Mastercouch as replacement for a standard couch.
    Radiother Oncol, 75(2): 227-36. [Abstract] [Full-text]
11. Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy.
    Radiother Oncol, 75(2): 204-9. [Abstract] [Full-text]
12. Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion.
    J Clin Endocrinol Metab, 90(8): 4483-8. [Abstract] [Full-text]
13. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy.
    Radiother Oncol, 75(2): 157-64. [Abstract] [Full-text]
14. Additional dose constraints for analytical beam weighting optimization in IMRT.
    Radiother Oncol, 75(2): 224-6. [Abstract] [Full-text]
15. Economic evaluation of proton radiation therapy in the treatment of breast cancer.
    Radiother Oncol, 75(2): 179-85. [Abstract] [Full-text]
16. CHART in lung cancer: economic evaluation and incentives for implementation.
    Radiother Oncol, 75(2): 171-8. [Abstract] [Full-text]
17. Dosimetric and clinical results of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma.
    Radiother Oncol, 75(2): 197-203. [Abstract] [Full-text]
18. Acupuncture for side effects of chemoradiation therapy in cancer patients.
    Semin Oncol Nurs, 21(3): 190-5. [Abstract] [Full-text]
19. Intravascular papillary endothelial hyperplasia at the superior orbital fissure: report of a case successfully treated with gamma knife radiosurgery.
    Surg Neurol, 64(3): 266-9; discussion 269. [Abstract] [Full-text]
20. Role of stereotactic radiosurgery as a primary treatment option in the management of newly diagnosed multiple (3-6) intracranial metastases.
    Surg Neurol, 64(3): 207-12. [Abstract] [Full-text]
21. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
    Semin Nucl Med, 35(3): 202-11. [Abstract] [Full-text]
22. Evaluation of therapy for lymphoma.
    Semin Nucl Med, 35(3): 186-96. [Abstract] [Full-text]
23. 188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study.
    Br J Haematol, 130(4): 604-13. [Abstract] [Full-text]
24. Breast conserving surgery and accelerated partial breast irradiation using the MammoSite system: initial clinical experience.
    Arch Surg, 140(8): 787-94. [Abstract] [Full-text]
25. Modelling the expected increase in demand for particle radiotherapy: implications for the UK.
    Br J Radiol, 78(933): 832-5. [Abstract] [Full-text]
26. Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.
    J Clin Oncol, 23(24): 5696-704. [Abstract] [Full-text]
27. Intraoperative fluoroscopic dose assessment in prostate brachytherapy patients.
    Int J Radiat Oncol Biol Phys, 63(1): 301-7. [Abstract] [Full-text]
28. An analysis of an implantable dosimeter system for external beam therapy.
    Int J Radiat Oncol Biol Phys, 63(1): 290-300. [Abstract] [Full-text]
29. Influence of radiotherapy on the latest generation of implantable cardioverter-defibrillators.
    Int J Radiat Oncol Biol Phys, 63(1): 282-9. [Abstract] [Full-text]
30. Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes.
    Int J Radiat Oncol Biol Phys, 63(1): 274-81. [Abstract] [Full-text]
31. Gamma camera scans and pretreatment tumor volumes as predictors of response and progression after Y-90 anti-CD20 radioimmunotherapy.
    Int J Radiat Oncol Biol Phys, 63(1): 194-201. [Abstract] [Full-text]
32. Esophagus sparing with IMRT in lung tumor irradiation: an EUD-based optimization technique.
    Int J Radiat Oncol Biol Phys, 63(1): 179-87. [Abstract] [Full-text]
33. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?
    Int J Radiat Oncol Biol Phys, 63(1): 155-63. [Abstract] [Full-text]
34. Rectal fistulas after prostate brachytherapy.
    Int J Radiat Oncol Biol Phys, 63(1): 150-4. [Abstract] [Full-text]
35. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Int J Radiat Oncol Biol Phys, 63(1): 141-9. [Abstract] [Full-text]
36. Effectiveness of fractionated stereotactic radiotherapy for uveal melanoma.
    Int J Radiat Oncol Biol Phys, 63(1): 116-22. [Abstract] [Full-text]
37. Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma.
    Int J Radiat Oncol Biol Phys, 63(1): 101-8. [Abstract] [Full-text]
38. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution.
    Int J Radiat Oncol Biol Phys, 63(1): 75-81. [Abstract] [Full-text]
39. MRI changes due to early-delayed conformal radiotherapy and postsurgical effects in patients with brain tumors.
    Int J Radiat Oncol Biol Phys, 63(1): 56-63. [Abstract] [Full-text]
40. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
    Int J Radiat Oncol Biol Phys, 63(1): 47-55. [Abstract] [Full-text]
41. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
    Int J Radiat Oncol Biol Phys, 63(1): 37-46. [Abstract] [Full-text]
42. Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning.
    Br J Haematol, 130(5): 733-9. [Abstract] [Full-text]
43. A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and 90Y-labeled rituximab in patients with refractory B-cell lymphoma.
    Cancer Biother Radiopharm, 20(4): 457-66. [Abstract] [Full-text]
44. The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases.
    Cancer Biother Radiopharm, 20(4): 450-6. [Abstract] [Full-text]
45. Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein.
    Cancer Biother Radiopharm, 20(4): 379-90. [Abstract] [Full-text]
46. MammoSite excision volume as a predictor for residual disease.
    Cancer, 104(5): 906-12. [Abstract] [Full-text]
47. A preliminary report on patient acceptance of a novel intra-oral lubricating device for the management of radiotherapy-related xerostomia.
    Clin Oral Investig, 9(3): 148-53. [Abstract] [Full-text]

© 2004-2008 Radiotherapy Research Today. All Rights Reserved.